New Rules at PhRMA to Change Industry's Image

May 11, 2017

The drug industry's main lobbying group is kicking out members that don't spend enough on developing new products.

According to new rules from the Pharmaceutical Research and Manufacturers of America that went into effect this week, in order to remain members, drug firms will have to spend at least 10 percent of their sales on global research and development over three years. They will also need to spend at least $200 million per year on R&D.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Relief Bill Signed

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

Little Bit Improved

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

PLOS Studies on Anti-Viral Epigenetic Drugs, Liver Cancer Oncogene, Brazilian HIV Diversity

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

Menu